Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.230
+0.030 (2.50%)
At close: May 23, 2025, 4:00 PM
1.210
-0.020 (-1.63%)
After-hours: May 23, 2025, 7:57 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $76.20 million as of May 23, 2025. Its market cap has decreased by -69.69% in one year.
Market Cap
76.20M
Enterprise Value
-9.39M
1-Year Change
-69.69%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $76.20M, a decrease of -85.45%. That is a compound annual growth rate of -41.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 76.20M | -17.86% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.36B |
| Johnson & Johnson | 364.35B |
| AbbVie | 319.01B |
| Novo Nordisk | 308.07B |
| UnitedHealth Group | 270.55B |
| Abbott Laboratories | 228.72B |
| Novartis AG | 222.59B |
| AstraZeneca | 218.71B |